A single dose, placebo controlled study of the fully human anti-tumor necrosis factor-alpha antibody adalimumab (D2E7) in patients with rheumatoid arthritis.
Year: 2002
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: PubMed
Institution: Radboud University Nijmegen
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1782927085